Digital Therapeutics (DTx) Market in terms of revenue was estimated to be worth $6.1 billion in 2023 and is poised to reach $21.9 billion by 2028, growing at a CAGR of 29.1% from 2023 to 2028 according to a new report by MarketsandMarkets™. The predominant factors fueling market growth include governmental initiatives supporting technological advancements and progress in the digital therapeutics field to mitigate escalating healthcare costs. Conversely, challenges to market growth stem from patient reluctance to adopt digital therapeutics and the instability of payment models.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724
Browse in-depth TOC on "Digital Therapeutics (DTx) Market"
290 - Tables
37 - Figures
309 - Pages
Digital Therapeutics (DTx) Market Scope:
Report Coverage | Details |
Market Revenue in 2023 | $6.1 billion |
Estimated Value by 2028 | $21.9 billion |
Growth Rate | Poised to grow at a CAGR of 29.1% |
Market Size Available for | 2021-2028 |
Forecast Period | 2023-2028 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Offering, By Revenue Model, Sales Channel, Application, and Region |
Geographies Covered | North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and the RoE), Asia Pacific (Japan, China, India, and the RoAPAC), Latin America (Brazil, Mexico, RoLATAM), and Middle East & Africa 9GCC Countries, RoMEA) |
Report Highlights | Updated financial information / product portfolio of players |
Key Market Opportunities | Large undiagnosed and untreated population |
Key Market Drivers | Rising focus on Preventative Healthcare |
The largest segment in the digital therapeutics market was acquired by treatment/care-related applications.
The digital therapeutics market's application segment is divided into preventive and treatment/care-related applications. In 2022 the treatment/care-related applications segment secured the market's largest share. Key drivers for this segment include the rise in healthcare costs and the cost-effective solutions offered by digital therapeutics. The market growth is further fueled by rising prevalence of disorder cardiovascular diseases, diabetes, substance abuse among others. Rising awareness regarding preventable disease such as prediabetes and obesity is estimated to drive the growth of preventable application segment. Digital therapeutics designed for prediabetes often include comprehensive lifestyle modification programs. These programs address key factors such as diet, physical activity, stress management, and sleep patterns. They provide personalized interventions to help individuals adopt healthier habits and manage their prediabetic condition.
The B2B segment represents the largest and fastest-growing category in the market over the forecast period.
The sales channel segment in the digital therapeutics market is categorized into business-to-business (B2B) and business-to-customer (B2C). In 2022, the B2B segment held the largest market share. This is attributed to the growing partnerships between prominent digital therapeutics providers and payers, providers, and employers, aimed at expanding their customer base. This collaboration significantly contributes to the increased sales of digital therapeutics solutions.
North America led the digital therapeutics market in 2022.
In 2022, the North American countries held the dominant market share, with Europe following closely behind. The North American market is anticipated to exhibit the highest CAGR. This growth is fueled by factors such as gradual improvement of reimbursement structures and increasing investments in digital therapeutics in the region. The US has witnessed a significant rise in chronic disease incidence, and managing a greater volume of patients poses a major challenge to the healthcare system in the country. Moreover, there is a greater focus on reducing rising healthcare costs. These factors are projected to drive the market in the coming years.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724
Digital Therapeutics (DTx) Market Dynamics:
Drivers:
- Rising focus on Preventative Healthcare
Restraint:
- Reluctance among patients to adopt digital therapeutics
Opportunities:
- Large undiagnosed and untreated population
Challenge:
- Lack of awareness and access to digital therapeutics programs in developing countries
Key Market Players of Digital Therapeutics (DTx) Industry:
Prominent players in the digital therapeutics market include Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc (US), Biofourmis (US), Better Therapeutics, Inc (US), Amalgm Rx (US), CogniFit Inc (US), Headspace Health (US), Propeller Health (US), Virta Health Corp (US), 2Morrow, Inc. (US), Realizedcare (US), Canary Health (US), Twill Inc. (US), Click Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt. Ltd. (India), Kaia Health (Germany), Ayogo (Canada), Mindable Health GmbH (Germany), Hinge Health, Inc. (US), and Freespira (US).
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 (50%), Tier 2 (30%), and Tier 3 (20%)
- By Designation: C-level (75%), D-level (15%), and Others (10%)
- By Region: North America (70%), Europe (20%), APAC (7%), and the RoW (3%)
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=51646724
Digital Therapeutics (DTx) Market - Key Benefits of Buying the Report:
The report aims to assist market leaders and new entrants by offering close approximations of revenue figures for both the overall digital therapeutics market and its subsegments. Stakeholders can leverage this report to comprehend the competitive landscape, acquire insights for strategic business positioning, and formulate effective go-to-market strategies. Additionally, it provides stakeholders with the means to assess the market dynamics and furnishes information on crucial market opportunities, restraints, drivers, and challenges.
